immunotherapy

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

immunotherapy
Sep 15, 2024, 00:29 | Insight
Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24
Agenus shared on LinkedIn: “Breelyn Wilky, presented new data at ESMO24 highlighting the potential of…
Sep 14, 2024, 06:23 | Blog
Patrick Forde: Presented data on adjuvant immunotherapy at WCLC2024 to help guide management of lung cancer
Patrick Forde, Professor at the Johns Hopkins University, posted the following on LinkedIn: “In the presidential…
Sep 13, 2024, 23:49 | Blog
Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting
Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…
Sep 13, 2024, 19:05 | Blog
Miriam Mutebi discusses Africa’s vulnerability in health supplies during COVID-19
Miriam Mutebi posted the following on LinkedIn: “The COVID-19 pandemic exposed Africa’s vulnerability in relying on…
Sep 13, 2024, 14:38 | Blog
Great summary and unresolved topics in current early NSCLC treatment landscape
Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn: ''Great…
Sep 13, 2024, 12:35 | Dialogues
MASCC Highlights: Surviving with Immunotoxicity | Christina Ruhlmann
In this episode of OncoDaily, Dr. Christina Ruhlmann, a clinical oncologist from Denmark, shares insights…
Sep 12, 2024, 21:39 | Blog
Dr. Carmen Julia Calfa shares a life-saving case of personalized cancer treatment - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared the following post on LinkedIn: “Dr. Carmen Julia Calfa met…
Sep 12, 2024, 21:07 | Blog
Vivek Subbiah: Delighted to host a JAMA Oncology Podcast with the amazing Eileen M. O'Reilly
Vivek Subbiah shared a post on LinkedIn: ''Such a delight to host a JAMA Oncology…
Sep 12, 2024, 14:42 | Insight
Colon Cancer Treatment: NICHE-2 Validates Immunotherapy
Maria Babak shared a post by The Babak Lab on LinkedIn: “ This research highlights…
Sep 11, 2024, 13:55 | Blog
Ana I. Velazquez Manana: Who benefits from adjuvant immunotherapy after neoadjuvant chemotherapy plus immunotherapy and surgery
Ana I. Velazquez Manana shared a post on X: ''Exploratory analysis comparing CM816 to CM77T…
Sep 11, 2024, 07:24 | Insight
A roadmap for designing better immunotherapies - Cancer Research Institute
Cancer Research Institute (CRI) made the following post on LinkedIn: "New findings from researchers, including…
Sep 10, 2024, 16:09 | Societies
Highlights from WCLC24 by Stephen V Liu Part 2
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 13:44 | Societies
There is still time to register for ESMO24
ESMO – European Society for Medical Oncology shared on LinkedIn: “ With ESMO24 just around…
Sep 9, 2024, 17:35 | Insight
Francisco J. Esteva: Combining cellular therapy with oncolytic virotherapy for stronger anti-tumor response
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Sep 9, 2024, 13:41 | Dialogues
Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13
Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…
Sep 9, 2024, 13:23 | Immune Oncology,Oncolibrary
Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared
When comparing immunotherapy vs chemotherapy, it's important to understand how these cancer treatments work differently.…
Sep 6, 2024, 15:44 | Insight
Jerónimo Rafael Rodríguez Cid: EGFR mutated patients doesnt have any benefit with immunotherapy in TKI's resistant tumors
Jerónimo Rafael Rodríguez Cid, Medical Oncologist in CDMX, shared a post on X: "We published…
Sep 6, 2024, 10:48 | Blog
OncoInfluencers to Follow on Social Media: Dr. Myriam Chalabi
We are thrilled to highlight Dr. Myriam Chalabi as a key figure in the oncology…
Sep 5, 2024, 15:47 | Blog
Many Minds. One Focus - The Brain Cancer Centre
The Brain Cancer Centre made the following post on LinkedIn: "Awesome to see our Research Rockstar…
Sep 4, 2024, 10:54 | Insight
Article of the day, September 4th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 19:41 | Insight
Kashyap Patel: Identify patients likely to respond to Immunotherapy based on Episwitch CIRT
Kashyap Patel shared a post by EpiSwitch CiRT on LinkedIn, adding: "We are embarking on…
Sep 2, 2024, 19:35 | Insight
Support Immunotherapy during Prostate Cancer Awareness Month
Cancer Research Institute shared on LinkedIn: “Did you know? September is Prostate Cancer Awareness Month.…
Sep 2, 2024, 18:35 | Blog
Dr. Owen O'Connor: The Vessel of Hope for Peripheral T-Cell Lymphoma Braves the Storm and Forges Ahead Fearlessly
MediaMedic made the following blog on LinkedIn: "In order to further improve the diagnostic and treatment…
Sep 2, 2024, 08:57 | Blog
Rasha Aboelhassan: Which maintenance immunotherapy should we choose for stage IV urothelial cancer
Rasha Aboelhassan shared a post on LinkedIn: "Which maintenance immunotherapy should we choose for stage…
Sep 1, 2024, 15:26 | Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Sep 1, 2024, 14:36 | Blog
Herbert Loong: Excellent multidisciplinary discussions on AYA Oncology
Herbert Loong shared a post on LinkedIn: "Many thanks to my Duke-NUS Medical School National…
Aug 30, 2024, 13:37 | Dialogues
United Against Cancer: Dr. Ahmed Elzawawy on Cost - Effective Treatments v1 | Dr. Zainab Shinkafi-Bagudu
In this episode of United Against Cancer, Dr. Ahmed Elzawawy, a renowned oncologist, discusses innovative…
Aug 28, 2024, 10:08 | Blog
Update of the progress in the management of esophageal cancers by Lorenzo Ferri at ISW24
International Surgical Week (ISW) 2024 is being held in Kuala Lumpur, Malaysia, from August 25…
Aug 27, 2024, 03:39 | Insight
Shuchi Gulati: Sumanta K. Pal on the role of gut microbiome to optimize immunotherapy in cancer at CCCC24
Shuchi Gulati, GU Oncologist at University of California Davis, shared on X: “Phenomenal talk from…
Aug 26, 2024, 20:45 | Insight
Adrienne Bruce Shannon: dMMR gastroesophageal cancer treated with immunotherapy
Adrienne Bruce Shannon, CGSO fellow at Moffitt Cancer Center, shared a post on X: "proud…
Aug 26, 2024, 16:59 | Blog
Stryder's Journey with Stage 4 High-Risk NeuroBlastoma - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: "When Stryder was diagnosed with stage 4 high-risk…
Aug 25, 2024, 16:16 | Blog
World - first lung cancer vaccine trials launched across 7 countries
Lung cancer remains the top cause of cancer deaths worldwide, claiming around 1.8 million lives…
Aug 25, 2024, 12:48 | Blog
The development of multimodal AI for clinical decision making in immunotherapy - NCI Systems Biology
NCI Systems Biology shared a post on X: "On Aug. 29 at 2:30 pm ET, Anant…
Aug 25, 2024, 09:49 | Insight
Elisa Agostinetto talks about immunotherapy at the International Breast Pathology Course in Mexico City
Elisa Agostinetto shared on LinkedIn: “It has been a real pleasure to talk about immunotherapy…
Aug 25, 2024, 08:59 | Blog
Trials in gynaecological cancers presented at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "Check out the trials in…
Aug 25, 2024, 02:22 | Blog
First patient dosed in the UK with a new lung cancer vaccine - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn: "Big news out today in the UK:…
Aug 23, 2024, 06:59 | Blog
Lazar Popovic: Glad to be part of the Faculty for ESMO preceptorship on Practising Oncology
Lazar Popovic, Professor at University of Novi Sad, posted on LinkedIn: "Glad to be part…
Aug 23, 2024, 06:22 | Blog
Highlights from the 2024 Seattle Cellular Therapy Summit
The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…
Aug 22, 2024, 20:56 | Blog
Lung Cancer Considered in Spanish: Neoadjuvant Therapies In NSCLC
Estela Rodriguez shared a post on X: "In this episode of IASLC's (The International Association…
Aug 22, 2024, 15:06 | Insight
Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy
Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn about…
Aug 22, 2024, 13:44 | Insight
Julia Lai-Kwon: How to select side-effects for ePRO symptom monitoring?
Julia Lai-Kwon shared on X: “Are you interested in how to select side-effects for ePRO…
Aug 21, 2024, 14:07 | Blog
MBI Researchers identify new immunotherapy targets for medulloblastoma
McKnight Brain Institute of the University of Florida shared on LinkedIn: "MBI researchers led a study…
Aug 20, 2024, 05:20 | Dialogues
Low-Grade Lymphomas: Dr. Joshua Brody on Treatments, Strategies, and Innovations
In this episode of OncoDaily interviews, Dr. Joshua Brody, director of the lymphoma immunotherapy program…
Aug 19, 2024, 06:51 | Insight
Chiara Corti: Our ASCO Daily News editorial "IMpassion132"
Chiara Corti shared a post on LinkedIn: "Check out our American Society of Clinical Oncology…
Aug 18, 2024, 20:56 | Blog
Tanya Dorff: Our 1st ⁦City of Hope GU program retreat
Tanya Dorff, Associate Professor of Clinical Medicine at City of Hope, shared on X: "Our…
Aug 17, 2024, 08:50 | Insight
Karl Semaan: Our study on first-line systemic therapy after adjuvant immunotherapy in RCC
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X…
Aug 17, 2024, 03:26 | Blog
Blocking METRNL to Boost Immunotherapy Effectiveness in Cancer Treatment
Cancer Research Institute (CRI) shared on LinkedIn: "According to researchers at Johns Hopkins Medicine, including…
Aug 16, 2024, 14:05 | Blog
Susanna F. Greer: This researcher took a note from Katy Perry
Susanna F. Greer shared an article on LinkedIn: “Imagine your DNA as a delicate thread.…
Aug 16, 2024, 12:12 | Blog
Dana Ataya: Patrick Hwu is the man that brought us all together
Dana Ataya, Breast Radiologist at Moffitt Cancer Center, shared a post on X: "Meet The Remissions…
Aug 15, 2024, 18:54 | Blog
ESTRO24 Highlights in radiobiology and SBRT
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "ESTRO24 Highlights in…
Aug 14, 2024, 13:29 | Blog
The development of multimodal AI for clincial decision making in immunotherapy
NCI Systems Biology shared a post on X: "On Aug. 29 at 2:30 pm ET,…
Aug 12, 2024, 13:32 | Blog
Tr1 cells: An unrecognized obstacle to Immunotherapy by Robert Schreiber - Cancer Research Institute
Cancer Research Institute shared on LinkedIn: "Aiming to understand and to address the limitations of immunotherapy,…
Aug 12, 2024, 12:46 | Blog
Eric H Yang: Immunotherapy cardiotoxicity is a relevant field for not just cardio-oncology but for cardiology as a whole
Eric H Yang, Director and Founder of the UCLA Cardio-Oncology Program, shared on X: "Thank…
Aug 12, 2024, 09:21 | Insight
Giuseppe Banna: RBC-based scores improving prognostic systems in metastatic RCC
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post…
Aug 12, 2024, 07:28 | Dialogues
Immunotherapy in Soft Tissue - 5 min Sarcoma Talk #6 with Sandra D'Angelo
In the new episode of "5 Minute Sarcoma Talk", Dr. Shushan Hovsepyan, the Editor-in-Chief of…
Aug 12, 2024, 05:52 | Blog
During the 2024 fiscal year, the Cancer Research Institute awarded $22,765,861 in research grants and fellowships
Cancer Research Institute shared a post on LinkedIn: "During the 2024 fiscal year, ending June…
Aug 10, 2024, 13:51 | Dialogues
Shushan Hovsepyan: Where does immunotherapy fit in the treatment landscape of sarcoma?
Shushan Hovsepyan shared on LinkedIn: "Where does immunotherapy fit in the treatment landscape of sarcoma?…
Aug 9, 2024, 10:21 | Insight
Immunotherapy with chemo improves survival for aggressive relapsed lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at…
Aug 9, 2024, 05:21 | Insight
Spatial profiling and phenotyping of tertiary lymphoid aggregates in head and neck cancer
Queensland Spatial Biology Centre shared a post on X about a recent paper by Habib…
Aug 9, 2024, 05:13 | Insight
Krishna Komanduri: CMV reactivation after CAR-T therapy for lymphoma
Recently, an article by Rick Lin et al. titled "Incidence and outcomes of cytomegalovirus reactivation…
Aug 7, 2024, 09:20 | Blog
Shushan Hovsepyan: Honored to interview Nils Eckardt
Shushan Hovsepyan shared a post by OncoDaily on LinkedIn, adding: ''I had the honor of…
Aug 6, 2024, 14:55 | Blog
Stephen Liu: Discussion on the emergence of immunotherapy in lung cancer
Stephen Liu shared on X: "Highlighting one of my favorite episodes of the IASLC podcast,…
Aug 6, 2024, 13:44 | Blog
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The Nobel Prize shared a post on LinkedIn: " 'Without him [Nobel Prize laureate James…
Aug 5, 2024, 17:22 | Blog
The 2025 SITC Spring Scientific on Cell Therapy for Solid Tumors
Society for Immunotherapy of Cancer shared a post on X: "Announcing the 2025 SITC Spring…
Aug 4, 2024, 06:32 | Insight
Elad Sharon: One of my favorite recent efforts from the SWOG Cancer Research Network's DART trial - a look at linear change in tumor size
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared JNCI's (Journal of the…
Aug 2, 2024, 08:47 | Dialogues
Driving Change in Oncology: the Vision of the Chief Medical Affairs Officer of Agenus
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Aug 1, 2024, 18:29 | Blog
Nazik Hammad: Thoroughly enjoyed this AORTIC medical oncology SIG case discussion on metastatic Colorectal Cancer
Nazik Hammad shared a post by AORTIC- Africa on LinkedIn, adding: “I thoroughly enjoyed this AORTIC medical…
Aug 1, 2024, 17:17 | Blog
John P. Leonard: We delve into the most exciting ASCO24 research
John P. Leonard, Professor of Hematology and Medical Oncology and Senior Associate Dean for Innovation…
Aug 1, 2024, 14:48 | Insight
Angela Mastronuzzi: The current landscape of CAR T-cell therapy for CNS tumors
Angela Mastronuzzi shared a post on LinkedIn about a recent paper titled "Chimeric antigen receptor…
Aug 1, 2024, 09:18 | Blog
Razelle Kurzrock: 4 ways to approach tumors with undruggable fusions
Razelle Kurzrock shared a post on X: "4 ways to approach tumors with undruggable fusions.…
Aug 1, 2024, 06:56 | Blog
Radiologic assessment before first line therapy for mccRCC
Cancer Network shared a post on X: ''Radiological tumor burden, if shown to have a…
Aug 1, 2024, 06:25 | Insight
Anne Knisely: Amir Jazaeri on special considerations for immunotherapy clinical trials
Anne Knisely, Gynaecology and Oncology fellow at MD Anderson Cancer Center, shared a post on…
Jul 31, 2024, 14:18 | Blog
Formycon announced start of clinical phase III trial for Keytruda biosimilar candidate FYB206
Formycon AG announced that the first patient has been enrolled in the Phase III clinical…
Jul 31, 2024, 03:54 | Blog
What is Immunotherapy? - Agenus
Agenus posted on LinkedIn: "Curious about immunotherapy? Swipe to learn how this innovative treatment boosts…
Jul 30, 2024, 13:25 | Insight
David Fajgenbaum: Untold story of a drug initially approved for Castleman Disease that saved a young girl's life
David Fajgenbaum shared on X: "Did you know that a repurposed drug saved the most…
Jul 30, 2024, 07:23 | Blog
HOPE Super Grant was awarded to Dr. Mitchell Cairo to support the development of new and improved ways to treat pediatric solid tumors
St. Baldrick's Foundation shared on LinkedIn: "For kids with osteosarcoma, a relapse is devastating, greatly…
Jul 29, 2024, 02:16 | Insight
Shahrin Ahmed: A significant increase in the number of clinical trials on Non-Hodgkin's lymphoma since 2019
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "In 2019,…
Jul 27, 2024, 22:17 | Insight
A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy - Weill Cornell Medicine
Weill Cornell Medicine shared on X: "A blood test that measures the number of lymphocytes…
Jul 26, 2024, 19:52 | Blog
Georgina Long: Beautiful Tasmania with Australian of the Year Awards spreading message of sun safety to kids
Georgina Long shared on X: "Beautiful Tasmania with Australian of the Year Awards. Spreading message…
Jul 26, 2024, 14:57 | Blog
Bernard Fox honored with a 2024 Society for Immunotherapy of Cancer Lifetime Achievement Award - Chiles Research Institute
Chiles Research Institute shared on X: "Congrats to Bernard Fox, Harder Family Chair for Cancer…
Jul 26, 2024, 08:01 | Blog
July 2024 Tip Sheet of Sylvester Comprehensive Cancer Center
This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…
Jul 26, 2024, 00:18 | Blog
Sara Tolaney on novel therapies for young women with breast cancer at Young Women's Forum
Young Women's Forum shared on X: "Honored to have Sara Tolaney, Chief of Breast Oncology…
Jul 25, 2024, 21:25 | Blog
Elad Sharon: Another win for patients with ALL
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X: "Another win for…
Jul 25, 2024, 13:04 | Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 25, 2024, 00:43 | Blog
Aaron Tallent: A new standard is poised to transform melanoma care
Aaron Tallent, Co-host of the Loaded Goat Podcast, shared on X: "A new standard is…
Jul 24, 2024, 14:48 | Dialogues
Cancer Control in Kazakhstan: HE Dr. Zainab Shinkafi Bagudu Interviews Dr. Dilyara Kaidarova
Join us for the premiere episode of our new interview series "United Against Cancer with…
Jul 24, 2024, 03:52 | Insight
Piotr Wysocki: The type of immunotherapy-related adverse event impacts the outcomes of anti-cancer immunotherapy
Piotr Wysocki recently posted on LinkedIn: “Understanding the co-occurrence patterns of immune-related adverse events (irAEs) across…
Jul 23, 2024, 07:41 | Blog
Tom Lynch: Fred Hutchinson Cancer Center expands immunotherapy offerings
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared a post…
Jul 20, 2024, 10:51 | Blog
Toni Choueiri: TiNivo2 results are out
Toni Choueiri shared a post on X: ''TiNivo2 results are out - adding PD1 inhibitor…
Jul 19, 2024, 22:19 | Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 19, 2024, 14:44 | Blog
"What’s Next for Immunotherapies?" by Anas Younes
Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies "My interview with Mark Cobbold, Senior…
Jul 19, 2024, 10:12 | Celebrities
Michael Douglas: The Untold Story of His Battle Against Cancer
Michael Douglas, says “My cancer has made me a free man.” Thirteen years after surviving…
Jul 19, 2024, 02:00 | Blog
I ask Agenus to consider Armenia as the first country to register the BOT/BAL combination: Gevorg Tamamyan
"~20% ORR and 90% alive at 6 months in comparison to ZERO! How many patients…
Jul 18, 2024, 11:08 | Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 18, 2024, 10:41 | Insight
Stephen Liu: Can we predict risk of immune related toxicity with immunotherapy for NSCLC
Stephen Liu shared a post on X about a recent paper by Fei Xing et…
Jul 18, 2024, 00:18 | Insight
Joshua Brody: Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on…
Jul 17, 2024, 21:50 | Blog
Kimryn Rathmell: New cellular immunotherapy may be effective in treating metastatic solid tumors
Kimryn Rathmell shared a post on X: ''Hot off the press from Steven Rosenberg and…
Jul 17, 2024, 02:26 | Insight
Patrick Hwu: When patients with solid tumors don’t respond to immunotherapy
Patrick Hwu shared a post on X about a recent paper by Maria Parkhurst et…
Jul 16, 2024, 16:01 | Blog
Submit an abstract for the AACR Special Conference on Tumor Immunology and Immunotherapy
AACR shared on LinkedIn: "Submit an abstract by August 5 for the AACR Special Conference on…
Jul 16, 2024, 10:50 | Blog
Social Determinants of Health with Large/Moderate Language Models on EHR Data
NCI Physical Sciences shared a post on X: Social Determinants of Health "On July 30…
All: 384 Posts: 1 - 100
Special Coverage